GBA deficiency promotes SNCA/α-synuclein accumulation through autophagic inhibition by inactivated PPP2A

References

• Thomas B, Beal MF. Parkinson disease. Hum Mol Genet 2007; 16 Spec No. Two:R183-94; PMID:17911161; http://dx.doi.org/10.1093/hmg/ddm159
   PubMedGoogle Scholar
• Devine MJ, Gwinn K, Singleton A, Hardy J. Parkinson disease and α-synuclein expression. Mov Disord 2011; 26:2160-8; PMID:21887711; http://dx.doi.org/10.1002/mds.23948
   PubMed Web of Science ®Google Scholar
• Lesage S, Brice A. Parkinson disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 2009; 18:R48-59; PMID:19297401; http://dx.doi.org/10.1093/hmg/ddp012
   PubMed Web of Science ®Google Scholar
• Mata IF, Samii A, Schneer SH, Roberts JW, Griffith A, Leis BC, Schellenberg GD, Sidransky E, Bird TD, Leverenz JB, et al. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol 2008; 65:379-82; PMID:18332251; http://dx.doi.org/10.1001/archneurol.2007.68
   PubMed Web of Science ®Google Scholar
• Mitsui J, Mizuta I, Toyoda A, Ashida R, Takahashi Y, Goto J, Fukuda Y, Date H, Iwata A, Yamamoto M, et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 2009; 66:571-6; PMID:19433656; http://dx.doi.org/10.1001/archneurol.2009.72
   PubMed Web of Science ®Google Scholar
• Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson disease. N Engl J Med 2009; 361:1651-61; PMID:19846850; http://dx.doi.org/10.1056/NEJMoa0901281
   PubMed Web of Science ®Google Scholar
• Lesage S, Anheim M, Condroyer C, Pollak P, Durif F, Dupuits C, Viallet F, Lohmann E, Corvol JC, Honore A, et al. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson disease. Hum Mol Genet 2011; 20:202-10; PMID:20947659; http://dx.doi.org/10.1093/hmg/ddq454
   PubMed Web of Science ®Google Scholar
• Brady RO, Kanfer J, Shapiro D. The Metabolism of Glucocerebrosides. I. Purification and Properties of a Glucocerebroside-Cleaving Enzyme from Spleen Tissue. J Biol Chem 1965; 240:39-43; PMID:14253443
   PubMed Web of Science ®Google Scholar
• Hruska KS, LaMarca ME, Scott CR, Sidransky E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 2008; 29:567-83; PMID:18338393; http://dx.doi.org/10.1002/humu.20676
   PubMed Web of Science ®Google Scholar
• Halperin A, Elstein D, Zimran A. Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. Blood Cells Mol Dis 2006; 36:426-8; PMID:16651014; http://dx.doi.org/10.1016/j.bcmd.2006.02.004
   PubMed Web of Science ®Google Scholar
• Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, et al. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology 2007; 69:1270-7; PMID:17875915; http://dx.doi.org/10.1212/01.wnl.0000276989.17578.02
   PubMed Web of Science ®Google Scholar
• Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology 2009; 72:310-6; PMID:18987351; http://dx.doi.org/10.1212/01.wnl.0000327823.81237.d1
   PubMed Web of Science ®Google Scholar
• Anheim M, Elbaz A, Lesage S, Durr A, Condroyer C, Viallet F, Pollak P, Bonaiti B, Bonaiti-Pellie C, Brice A. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology 2012; 78:417-20; PMID:22282650; http://dx.doi.org/10.1212/WNL.0b013e318245f476
   PubMed Web of Science ®Google Scholar
• Wong K, Sidransky E, Verma A, Mixon T, Sandberg GD, Wakefield LK, Morrison A, Lwin A, Colegial C, Allman JM, et al. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab 2004; 82:192-207; PMID:15234332; http://dx.doi.org/10.1016/j.ymgme.2004.04.011
   PubMed Web of Science ®Google Scholar
• Gegg ME, Burke D, Heales SJ, Cooper JM, Hardy J, Wood NW, Schapira AH. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann Neurol 2012; 72:455-63; PMID:23034917; http://dx.doi.org/10.1002/ana.23614
   PubMed Web of Science ®Google Scholar
• Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, Sidransky E, Grabowski GA, Krainc D. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011; 146:37-52; PMID:21700325; http://dx.doi.org/10.1016/j.cell.2011.06.001
   PubMed Web of Science ®Google Scholar
• Cullen V, Sardi SP, Ng J, Xu YH, Sun Y, Tomlinson JJ, Kolodziej P, Kahn I, Saftig P, Woulfe J, et al. Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing. Ann Neurol 2011; 69:940-53; PMID:21472771; http://dx.doi.org/10.1002/ana.22400
   PubMed Web of Science ®Google Scholar
• Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, Gindi R, Adame A, Wyss-Coray T, Masliah E. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in α-synuclein models of Parkinson and Lewy body diseases. J Neurosci 2009; 29:13578-88; PMID:19864570; http://dx.doi.org/10.1523/JNEUROSCI.4390-09.2009
   PubMed Web of Science ®Google Scholar
• Chen J, Martin BL, Brautigan DL. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 1992; 257:1261-4; PMID:1325671; http://dx.doi.org/10.1126/science.1325671
   PubMed Web of Science ®Google Scholar
• Pitre A, Davis N, Paul M, Orr AW, Skalli O. Synemin promotes AKT-dependent glioblastoma cell proliferation by antagonizing PP2A. Mol Biol Cell 2012; 23:1243-53; PMID:22337773; http://dx.doi.org/10.1091/mbc.E11-08-0685
   PubMed Web of Science ®Google Scholar
• Kar S, Palit S, Ball WB, Das PK. Carnosic acid modulates Akt/IKK/NF-kappaB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Apoptosis 2012; 17:735-47; PMID:22453599; http://dx.doi.org/10.1007/s10495-012-0715-4
   PubMed Web of Science ®Google Scholar
• Mitra A, Menezes ME, Pannell LK, Mulekar MS, Honkanen RE, Shevde LA, Samant RS. DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3beta to downregulate β-catenin transcription target, osteopontin. Oncogene 2012; 31:4472-83; PMID:22266849; http://dx.doi.org/10.1038/onc.2011.623
   PubMed Web of Science ®Google Scholar
• Yorimitsu T, He C, Wang K, Klionsky DJ. Tap42-associated protein phosphatase type 2A negatively regulates induction of autophagy. Autophagy 2009; 5:616-24; PMID:19223769; http://dx.doi.org/10.4161/auto.5.5.8091
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8:445-544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496
   PubMed Web of Science ®Google Scholar
• Shacka JJ, Klocke BJ, Roth KA. Autophagy, bafilomycin and cell death: the “a-B-cs" of plecomacrolide-induced neuroprotection. Autophagy 2006; 2:228-30; PMID:16874105; http://dx.doi.org/10.4161/auto.2703
   PubMed Web of Science ®Google Scholar
• Scarlatti F, Bauvy C, Ventruti A, Sala G, Cluzeaud F, Vandewalle A, Ghidoni R, Codogno P. Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1. J Biol Chem 2004; 279:18384-91; PMID:14970205; http://dx.doi.org/10.1074/jbc.M313561200
   PubMed Web of Science ®Google Scholar
• Komatsu M, Ichimura Y. Physiological significance of selective degradation of p62 by autophagy. FEBS Lett 2010; 584:1374-8; PMID:20153326; http://dx.doi.org/10.1016/j.febslet.2010.02.017
   PubMed Web of Science ®Google Scholar
• Sontag E, Nunbhakdi-Craig V, Sontag JM, Diaz-Arrastia R, Ogris E, Dayal S, Lentz SR, Arning E, Bottiglieri T. Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J Neurosci 2007; 27:2751-9; PMID:17360897; http://dx.doi.org/10.1523/JNEUROSCI.3316-06.2007
   PubMed Web of Science ®Google Scholar
• Cook C, Stetler C, Petrucelli L. Disruption of protein quality control in Parkinson disease. Cold Spring Harb Perspect Med 2012; 2:a009423; PMID:22553500; http://dx.doi.org/10.1101/cshperspect.a009423
   PubMed Web of Science ®Google Scholar
• Ding WX, Yin XM. Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 2008; 4:141-50; PMID:17986870; http://dx.doi.org/10.4161/auto.5190
   PubMed Web of Science ®Google Scholar
• Neumann J, Bras J, Deas E, O'Sullivan SS, Parkkinen L, Lachmann RH, Li A, Holton J, Guerreiro R, Paudel R, et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson disease. Brain 2009; 132:1783-94; PMID:19286695; http://dx.doi.org/10.1093/brain/awp044
   PubMed Web of Science ®Google Scholar
• Kahle PJ. α-Synucleinopathy models and human neuropathology: similarities and differences. Acta Neuropathol 2008; 115:87-95; PMID:17932682; http://dx.doi.org/10.1007/s00401-007-0302-x
   PubMed Web of Science ®Google Scholar
• Dermentzaki G, Dimitriou E, Xilouri M, Michelakakis H, Stefanis L. Loss of β-glucocerebrosidase activity does not affect α-synuclein levels or lysosomal function in neuronal cells. PLoS One 2013; 8:e60674; PMID:23580063; http://dx.doi.org/10.1371/journal.pone.0060674
   PubMed Web of Science ®Google Scholar
• Friedman LG, Lachenmayer ML, Wang J, He L, Poulose SM, Komatsu M, Holstein GR, Yue Z. Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of α-synuclein and LRRK2 in the brain. J Neurosci 2012; 32:7585-93; PMID:22649237; http://dx.doi.org/10.1523/JNEUROSCI.5809-11.2012
   PubMed Web of Science ®Google Scholar
• Klucken J, Poehler AM, Ebrahimi-Fakhari D, Schneider J, Nuber S, Rockenstein E, Schlotzer-Schrehardt U, Hyman BT, McLean PJ, Masliah E, et al. Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway. Autophagy 2012; 8:754-66; PMID:22647715; http://dx.doi.org/10.4161/auto.19371
   PubMed Web of Science ®Google Scholar
• Osellame LD, Rahim AA, Hargreaves IP, Gegg ME, Richard-Londt A, Brandner S, Waddington SN, Schapira AH, Duchen MR. Mitochondria and quality control defects in a mouse model of Gaucher disease–links to Parkinson disease. Cell Metab 2013; 17:941-53; PMID:23707074; http://dx.doi.org/10.1016/j.cmet.2013.04.014
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Criollo A, Kroemer G. Crosstalk between apoptosis and autophagy within the Beclin 1 interactome. EMBO J 2010; 29:515-6; PMID:20125189; http://dx.doi.org/10.1038/emboj.2009.377
   PubMed Web of Science ®Google Scholar
• Murphy KE, Gysbers AM, Abbott SK, Tayebi N, Kim WS, Sidransky E, Cooper A, Garner B, Halliday GM. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson disease. Brain 2014; 137:834-48; PMID:24477431; http://dx.doi.org/10.1093/brain/awt367
   PubMed Web of Science ®Google Scholar
• Veeranna Yang DS, Lee JH, Vinod KY, Stavrides P, Amin ND, Pant HC, Nixon RA. Declining phosphatases underlie aging-related hyperphosphorylation of neurofilaments. Neurobiol Aging 2011; 32:2016-29; PMID:20031277; http://dx.doi.org/10.1016/j.neurobiolaging.2009.12.001
   PubMed Web of Science ®Google Scholar
• Magnaudeix A, Wilson CM, Page G, Bauvy C, Codogno P, Leveque P, Labrousse F, Corre-Delage M, Yardin C, Terro F. PP2A blockade inhibits autophagy and causes intraneuronal accumulation of ubiquitinated proteins. Neurobiol Aging 2013; 34:770-90; PMID:22892312; http://dx.doi.org/10.1016/j.neurobiolaging.2012.06.026
   PubMed Web of Science ®Google Scholar
• Ruvolo PP, Clark W, Mumby M, Gao F, May WS. A functional role for the B56 α-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function. J Biol Chem 2002; 277:22847-52; PMID:11929874; http://dx.doi.org/10.1074/jbc.M201830200
   PubMed Web of Science ®Google Scholar
• Mitoma J, Ito M, Furuya S, Hirabayashi Y. Bipotential roles of ceramide in the growth of hippocampal neurons: promotion of cell survival and dendritic outgrowth in dose- and developmental stage-dependent manners. J Neurosci Res 1998; 51:712-22; PMID:9545085; http://dx.doi.org/10.1002/(SICI)1097-4547(19980315)51:6%3c712::AID-JNR5%3e3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Tsujio I, Zaidi T, Xu J, Kotula L, Grundke-Iqbal I, Iqbal K. Inhibitors of protein phosphatase-2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau. FEBS Lett 2005; 579:363-72; PMID:15642345; http://dx.doi.org/10.1016/j.febslet.2004.11.097
   PubMed Web of Science ®Google Scholar
• Chen S, Li B, Grundke-Iqbal I, Iqbal K. I1PP2A affects tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A. J Biol Chem 2008; 283:10513-21; PMID:18245083; http://dx.doi.org/10.1074/jbc.M709852200
   PubMed Web of Science ®Google Scholar
• Yu XX, Du X, Moreno CS, Green RE, Ogris E, Feng Q, Chou L, McQuoid MJ, Pallas DC. Methylation of the protein phosphatase 2A catalytic subunit is essential for association of Balpha regulatory subunit but not SG2NA, striatin, or polyomavirus middle tumor antigen. Mol Biol Cell 2001; 12:185-99; PMID:11160832; http://dx.doi.org/10.1091/mbc.12.1.185
   PubMed Web of Science ®Google Scholar
• Janssens V, Longin S, Goris J. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem Sci 2008; 33:113-21; PMID:18291659; http://dx.doi.org/10.1016/j.tibs.2007.12.004
   PubMed Web of Science ®Google Scholar
• Sontag E, Hladik C, Montgomery L, Luangpirom A, Mudrak I, Ogris E, White CL, 3rd. Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J Neuropathol Exp Neurol 2004; 63:1080-91; PMID:15535135
   PubMed Web of Science ®Google Scholar
• Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Speciale S, White CL, 3rd. Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 2004; 63:287-301; PMID:15099019
   PubMed Web of Science ®Google Scholar
• Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC. Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 2003; 278:25009-13; PMID:12719433; http://dx.doi.org/10.1074/jbc.M300227200
   PubMed Web of Science ®Google Scholar
• Yu WH, Dorado B, Figueroa HY, Wang L, Planel E, Cookson MR, Clark LN, Duff KE. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric α-synuclein. Am J Pathol 2009; 175:736-47; PMID:19628769; http://dx.doi.org/10.2353/ajpath.2009.080928
   PubMed Web of Science ®Google Scholar
• Sardi SP, Clarke J, Viel C, Chan M, Tamsett TJ, Treleaven CM, Bu J, Sweet L, Passini MA, Dodge JC, et al. Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. Proc Natl Acad Sci U S A 2013; 110:3537-42; PMID:23297226; http://dx.doi.org/10.1073/pnas.1220464110
   PubMed Web of Science ®Google Scholar
• Yap TL, Velayati A, Sidransky E, Lee JC. Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity. Mol Genet Metab 2013; 108:56-64; PMID:23266198; http://dx.doi.org/10.1016/j.ymgme.2012.11.010
   PubMed Web of Science ®Google Scholar
• Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B. The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci 2000; 20:6048-54; PMID:10934254
   PubMed Web of Science ®Google Scholar
• Zhu Y, Duan C, Lu L, Gao H, Zhao C, Yu S, Ueda K, Chan P, Yang H. α-Synuclein overexpression impairs mitochondrial function by associating with adenylate translocator. Int J Biochem Cell Biol 2011; 43:732-41; PMID:21310263; http://dx.doi.org/10.1016/j.biocel.2011.01.014
   PubMed Web of Science ®Google Scholar
• Yang W, Wang X, Duan C, Lu L, Yang H. Alpha-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex. Neurochem Int 2013; 63:180-94; PMID:23796501; http://dx.doi.org/10.1016/j.neuint.2013.06.010
   PubMed Web of Science ®Google Scholar
• Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226:497-509; PMID:13428781
   PubMed Web of Science ®Google Scholar